SENSEX NIFTY
YOU ARE HERE > MONEYCONTROL > MARKETS > PHARMACEUTICALS > News - Dr Reddys Laboratories
Dr Reddys Laboratories
BSE: 500124|NSE: DRREDDY|ISIN: INE089A01023|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Apr 24, 17:00
3485.85
-38.45 (-1.09%)
VOLUME 12,384
LIVE
NSE
Apr 24, 17:00
3484.15
-44.65 (-1.27%)
VOLUME 186,232

Stock Advice on Dr Reddys Laboratories

Select Year: 2013 |  2012 |  2011 | 2010 | 2009 | 2008 | 2007 | 2000-2006
Stay away from pharma space, see deep correction: Sukhani 

12.03 pm | 22 Apr 2015 |  Source: CNBC-TV18

Sudarshan Sukhani of s2analytics.com is of the view that one may avoid the pharma space as it may witness deeper correction....

Prefer pharma, telecom stocks: Ajay Srivastava 

11.23 am | 20 Apr 2015 |  Source: CNBC-TV18

Ajay Srivastava, CEO at Dimensions Consulting is of the view that one may prefer pharma and telecom stocks as they are going to give the best returns ...

Nifty may not hit 9K in a hurry; like Glenmark: PhillipCap 

11.12 am | 16 Apr 2015 |  Source: CNBC-TV18

Going ahead, Vineet Bhatnagar, managing director, Phillip Capital expects refinery, oil marketing companies and ONGC to show strong upward moves. He a...

Look at healthcare space: Sandeep Shenoy 

11.02 am | 10 Apr 2015 |  Source: CNBC-TV18

Sandeep Shenoy of Pioneer Investcorp is of the view that one may look at healthcare space....

Book profits in pharma: Sudarshan Sukhani 

11.53 am | 09 Apr 2015 |  Source: CNBC-TV18

Sudarshan Sukhani of s2analytics.com is of the view that one can book profits in pharma stocks....

Earnings surprise unlikely from pharma; like Glenmark: Pal 

2.58 pm | 08 Apr 2015 |  Source: CNBC-TV18

Based on valuations, Surajit Pal of Prabhudas Lilladher is very bullish on Glenmark first then Aurobindo and Dr Reddy’s. ...

Buy Glenmark Pharma, says Deepak Shenoy 

1.25 pm | 08 Apr 2015 |  Source: CNBC-TV18

Deepak Shenoy, founder of capitalmind.in recommends buying Glenmark Pharma....

Here are top 10 stocks to focus on April 8 

8.46 am | 08 Apr 2015 |  Source: CNBC-TV18

Here are top 10 stocks to focus on April 8 - Jubilant Life, Exide, SBI, HDFC Bank, ICICI Bank, Dr Reddys, DLF, HDIL, SKS Micro and Coal India....

Buy Dr Reddy's Labs; sell Reliance Infra, Zee Ent: Sukhani 

2.47 pm | 06 Apr 2015 |  Source: CNBC-TV18

Sudarshan Sukhani of s2analytics.com recommends buying Dr Reddy's Labs and advises selling Reliance Infrastructure and Zee Entertainment Enterprises....

Buy Dr Reddy's Labs, says Sudarshan Sukhani 

11.02 am | 01 Apr 2015 |  Source: CNBC-TV18

Sudarshan Sukhani of s2analytics.com is of the view that one can buy Dr Reddy’s Laboratories....

Mithil Pradhan bullish on pharma space 

5.15 pm | 31 Mar 2015 |  Source: CNBC-TV18

Mithil Pradhan of Violet Arc Global Managers has a bullish stance on pharma space....

Post Q4 commentary important; like banks: P Lilladher 

12.35 pm | 26 Mar 2015 |  Source: CNBC-TV18

R Sreesankar of Prabhudas Lilladher says commentary post Q4 of FY15 will be important. He recommends investors to ‘accumulate’ pharma stocks thoug...

Here are some trading ideas from Chandan Taparia 

9.42 am | 25 Mar 2015 |  Source: CNBC-TV18

Watch the interview of Chandan Taparia of Anand Rathi Securities with Latha Venkatesh & Sonia Shenoy on CNBC-TV18, in which he shared his readings and...

Prefer Dr Reddy’s Labs: Mayuresh Joshi 

4.51 pm | 24 Mar 2015 |  Source: CNBC-TV18

Mayuresh Joshi of Angel Broking is of the view that one may prefer Dr Reddy’s Labs....

Avoid pharma stocks: Sudarshan Sukhani 

4.43 pm | 23 Mar 2015 |  Source: CNBC-TV18

Sudarshan Sukhani of s2analytics.com is of the view that one may avoid pharma space....

Quick Links for Dr Reddys Laboratories
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.